Journal of Osteoporosis / 2016 / Article / Tab 1

Research Article

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis

Table 1

Baseline clinical characteristics of all patients ().

Baseline

Age (years) 67.72 ± 0.48
Body mass index (kg/m2) 24.23 ± 0.25
Serum calcium (mg/dL) 9.46 ± 0.02
Urinary calcium (mg/24 h)169.00 ± 6.48
Serum phosphate (mg/dL) 3.84 ± 0.03
25(OH)vitamin D (ng/mL) 33.98 ± 0.73
iPTH (pg/mL) 46.80 ± 1.01
tAP (IU/L) 149.40 ± 5.65
BGP (ng/mL) 19.33 ± 0.75
s-CTX (ng/L) 332.40 ± 14.39
Lumbar spine BMD (g/cm2; -score)0.864 ± 0.006; −2.70 ± 0.06
Femoral neck BMD (g/cm2; -score)0.742 ± 0.006; −2.38 ± 0.05
Total hip BMD (g/cm2; -score)0.747 ± 0.006; −2.17 ± 0.05

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.